Guidance

Coronavirus (COVID-19): evaluation of submissions of diagnostic products

How the Department of Health and Social Care evaluates the submissions of commercially available COVID-19 diagnostic products.

• From: Department of Health and Social Care
• Published: 20 March 2020
• Last updated: 14 April 2020
  Show all updates

  1. 14 April 2020

     Added following bullet point under list of criteria on which a decision to progress to stage 2 of the rapid evaluation process is based: 'whether the product does or does not conform to any relevant published guidance'.

  2. 13 April 2020

     Updated contact information

  3. 27 March 2020

     Updated email address.

  4. 20 March 2020

     First published.

This publication was withdrawn on 29 April 2022

This page has been withdrawn because it’s no longer current. Read more about living safely with coronavirus (COVID-19).

Documents

[Withdrawn] Guidance for industry on evaluations of diagnostic products for coronavirus (COVID-19)

HTML

Details

This document provides guidance on how the Department of Health and Social Care evaluates approaches from industry to encourage diagnostic and other scientific innovation.